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Abstract: 1’-(S)-1’-Acetoxychavicol acetate (ACA) isolated from the Malaysian ethno-
medicinal plant Alpinia conchigera Griff. was investigated for its potential as an anticancer 
drug. In this communication, we describe the cytotoxic and apoptotic properties of ACA on 
five human tumour cell lines. Data from MTT cell viability assays indicated that ACA 
induced both time- and dose-dependent cytotoxicity on all tumour cell lines tested and had 
no adverse cytotoxic effects on normal cells. Total mortality of the entire tumour cell 
population was achieved within 30 hrs when treated with ACA at 40.0 µM concentration. 
Flow cytometric analysis for annexin-V and PI dual staining demonstrated that cell death 
occurred via apoptosis, followed by secondary necrosis. The apoptotic effects of ACA 
were confirmed via the DNA fragmentation assay, in which consistent laddering of 
genomic DNA was observed for all tumour cell lines after a 24 hrs post-treatment period at 
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the IC50 concentration of ACA. A cell cycle analysis using PI staining also demonstrated 
that ACA induced cell cycle arrest at the G0/G1 phase, corresponding to oral tumour cell 
lines. In conclusion, ACA exhibits enormous potential for future development as a 
chemotherapeutic drug against various malignancies. 
Keywords: 1’-(S)-1’-acetoxychavicol acetate; Alpinia conchigera; apoptosis; cytotoxicity; 
cell cycle arrest 
 
1. Introduction  
Medicinal herbs have always been used as traditional primary health care agents, especially in 
Asian countries, and over the last 20 years, there have been rapid changes in the popularity of the use 
of natural systems to maintain health and for alternative therapy [1,2]. However, scientific studies on 
the use of most traditional medicinal plants to ensure their efficacy and non-toxicity have not been 
carried out. 
The plant Alpinia conchigera Griff. (Family: Zingiberaceae; Section: Zingiberacea; Sub-section: 
Strobidia) is known locally as lengkuas ranting, lengkuas kecil, lengkuas padang, lengkuas geting or 
chengkenam [3–5]. It is a herbaceous perennial, 2-5 ft. tall, found in Eastern Bengal and southward 
towards Peninsular Malaysia and Sumatera (Sumatra) [6,7]. It is used as a condiment in the northern 
state of Peninsular Malaysia and occasionally in traditional medicine on the east coast to treat fungal 
infections [8]. In Thailand, the rhizomes are used in traditional Thai medicine to relieve gastro-
intestinal disorders and in the preparation of Thai food dishes [9].  
1’-(S)-1’-Acetoxychavicol acetate (ACA, Figure 1), which can be isolated from Alpinia conchigera, 
has been the subject of various biological activity studies. One of the early studies with this compound 
showed its in vitro inhibitory effects on tumour-promoted-induced Epstein-Barr virus activation [10]. 
Subsequent studies demonstrated that ACA inhibits Ehrlich ascites tumour cells, skin tumour 
promotion and adenocarcinoma formation [11–14]. More recently, ACA was shown to inhibit the 
cellular growth of the hematological malignant cells in vitro and in vivo by the induction of apoptosis 
via mitochondrial- and Fas-mediated dual mechanism in myeloid leukemic cells [15]. Because of our 
interest in the antitumourigenic properties of traditional herbs, our goal was to investigate the potential 
of ACA to induce apoptosis in various human tumour cells: breast adenocarcinoma (MCF-7), oral 
squamous carcinoma (HSC-2 and HSC-4), hepatocyte carcinoma (HepG2) and epidermoid cervical 
carcinoma (CaSki). This communication therefore describes the cytotoxic and apoptotic properties of 
1’S-1’-acetoxychavicol acetate on various human malignancies in vitro to better understand its 
potential therapeutic value. 
Figure 1. Chemical structure of 1’S-1’-acetoxychavicol acetate.  
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2. Results and Discussions 
2.1. LC-MS Analysis  
1’-(S)-1’-Acetoxychavicol acetate (ACA) was injected into an LC-MS system to give a 
chromatogram (Figure 2) recorded at 254 nm, in which ACA gave a strong peak at tR = 4.1 min. 
Figure 2. Chromatogram of 1’S-1’-acetoxychavicol acetate at 254 nm. 
 
2.2. ACA Induced Dose- and Time-Dependent Cytotoxic in Tumour Cells 
To determine if cytotoxicity was dose- and time-dependant, the MTT cell viability assay which 
measures the mitochondrial activity in viable cells was conducted. Results indicated that cells treated 
with ACA induced cytotoxicity in a dose dependant manner. Highest levels of cytotoxicity were 
observed in oral squamous carcinoma cells (HSC-4 and HSC-2), with IC50 values of 8.0 µM and  
9.0 µM, respectively, at 12 hrs post-treatment time (Figure 3A). At 80.0 µM ACA concentration, more 
than 80% of tumour cells assayed died after 12 hrs of exposure to ACA (Figure 3A). MTT assay data 
in Figure 3B demonstrated that the cytotoxic effects of ACA on tumour cell lines were also time 
dependant. At 40.0 µM, all cell lines were killed after a 30 hrs incubation period and the viability of all 
cell lines were reduced to 40%–50% after 12 hrs of ACA treatment, with the exception of HepG2 cells 
(Figure 3B). Reductions in cell viability was once again found to be greatest in HSC-4 and HSC-2 
cells, indicating that ACA induced cell death most efficiently in oral squamous carcinoma type cells 
(Figure 3B). The 12 hrs IC50 values of ACA in all cancer cell lines with the exception of HSC-2 and 
HSC-4 oral cancer cell lines, were considerably high, ranging from 34.0 µM to 48.0 µM in MCF-7, 
HepG2 and CaSki cell lines. This suggested the primary application of ACA against oral carcinomas, 
consistent with reports indicating the traditional consumption of Alpinia conchigera rhizomes orally. 
Viability of cells treated with DMSO without ACA were insignificantly affected (<1.0%; data not 
shown), indicating that cytotoxicity was induced by ACA and not the DMSO solvent, which has been 
reported to be cytotoxic at high concentrations [16]. Figure 3A and 3B also indicated that no adverse 
cytotoxic effects were observed when treated with HMEC normal human cells with viability levels 
maintained above 90.0%. Based on initial MTT assay results, the concentration of ACA in all 
subsequent experiments were set at the IC50 value of respective cell lines with a 12 hrs incubation time 
(Table 1). Both time and dose dependant assays supported the need to further investigate the apoptotic 
effects of ACA in oral cancer cells. 
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Table 1. IC50 values of ACA in various human cancer cell lines at different incubation periods. 
Human Cancer 
Cell Lines 
IC50 
value (µM) 
Incubation 
Time (hours) 
Breast adenocarcinoma (MCF-7) 
 
Oral squamous carcinoma (HSC-2) 
 
Oral squamous carcinoma (HSC-4) 
 
Hepatocyte carcinoma (HepG2) 
 
Epidermoid cervical carcinoma (CaSki) 
34.0* 
30.0 
9.0* 
5.0 
8.0* 
5.5 
48.0* 
18.0 
48.0* 
17.0 
12* 
24 
12* 
24 
12* 
24 
12* 
24 
12* 
24 
*Denotes treatment parameters used in flow cytometry and DNA fragmentation assays. 
Figure 3. The cytotoxic effects of ACA on tumour cell lines assessed using the MTT cell 
viability assay. (A) Comparison of total viable cell count between various tumour cell lines 
after treatment with ACA at different concentrations (0–80.0 µM) at 12 hrs post-treatment 
time. (B) Comparison of total viable cell count between various tumor cell lines after 
treatment with 40.0 µM ACA for 30 hrs. All experiments were plotted as mean values (n = 3). 
 
 
 
(B) 
(A) 
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2.3. ACA Induced-Potential Cell Cycle Arrest at the G0/G1 Phase 
As cytotoxicity was best demonstrated on oral cancer cells, we next compared the cell cycle 
distribution patterns before and after ACA treatment. Both attached and floating oral cancer cells were 
stained with propidium iodide and analyzed by flow cytometry. Cultivation with ACA significantly 
decreased the population of HSC-2 and HSC-4 cells in the G0/G1 phase, indicating a potential arrest 
during the pre-DNA replication G0/G1 checkpoint (Figures 4A and 4B). Both tumour cell lines also 
demonstrated an indication of apoptosis by the appearance of a hypodiploid DNA peak within the sub-
G1 phase 24 hrs after ACA exposure (Figures 4A and 4B). 
Figure 4. Cell cycle distribution of cancer cell lines using flow cytometry after staining 
with PI. (A) HSC-2 cells treated with ACA; (B) HSC-4 cells treated with ACA. M1:  
Sub-G1 phase; M2:G0/G1 phase; M3:S phase; M4:G2/M phase. All experiments are a 
representative of 10,000 cells and the percentage of cells in all cell cycle phases are 
indicated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4. ACA Induced Cell Death via Apoptosis 
In order to investigate if tumour cells were dying through apoptosis as opposed to primary necrosis, 
a double fluorescence staining of annexin V-FITC conjugate and propidium iodide was performed on 
tumour cells before and after IC50 ACA treatment, and analyzed using a flow cytometer. After 
# 
C
el
ls 
M1
M2
M3
M4
M1
M2
M3
M4
M1: 5.82% 
M2: 50.11% 
M1
M2
M3
M4
M1: 15.86% 
M2: 40.23% 
HSC-2 
Untreated 
HSC-2 
ACA (12H) 
HSC-2 
ACA (24H) 
DNA content DNA content DNA content 
M1: 0.05% 
M2: 52.73% 
(A) 
# 
C
el
ls 
M1
M2
M3
M4
M1
M2
M3
M4
M1
M2
M3
M4
M1: 18.77% 
M2: 62.48% 
M1: 21.73% 
M2: 50.37% 
HSC-4 
Untreated 
HSC-4 
ACA (12H) 
HSC-4 
ACA (24H) 
DNA content DNA content DNA content 
M1: 3.92% 
M2: 73.96% 
(B) 
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exposure of all five tumour cell lines to ACA for 12 hrs and 24 hrs, the population of cells indicated a 
shift from viable cells to early stage and late stage apoptosis, followed by secondary necrosis. HSC-2 
cells displayed a higher percentage of apoptotic cells with 76.94% compared to HSC-4 cells with 
19.46% (Figures 5A and 5B). Agarose gel electrophoresis of DNA extracted from cancer cells treated 
with ACA demonstrated partial and complete fragmentation of genomic DNA after 12 hrs and 24 hrs, 
respectively (Figure 6). This confirmed the induction of apoptosis, in which the consistent laddering of 
genomic DNA represents one of the major hallmarks of apoptosis. 
Figure 5. Detection of apoptosis using flow cytometry after annexin V-FITC/ propidium 
iodide (PI) staining indicating that ACA potentiates apoptosis-mediated cell death after 12 
hrs and 24 hrs of exposure. (A) HSC-2 cells treated with ACA; (B) HSC-4 cells treated 
with ACA. Viable cells are in the lower left quadrant, early apoptotic cells are in the lower 
right quadrant, late apoptotic cells are in the upper right quadrant and non-viable necrotic 
cells are in the upper left quadrant. Dot plots are a representative of 10,000 cells from a 
single replicate. 
 
 
 
(A) HSC-2 
Untreated 
HSC-2 
ACA (12 Hrs) 
HSC-2 
ACA (24 Hrs) 
Annexin V-FITC Annexin V-FITC Annexin V-FITC 
0.48% 
16.95% 
7.96% 
0.04% 40.62% 
36.32% 0.23% 5.37% 12.56% 
PI
 
(B) HSC-4 
Untreated 
HSC-4 
ACA (12 Hrs) 
HSC-4 
ACA (24 Hrs) 
Annexin V-FITC Annexin V-FITC Annexin V-FITC 
1.45% 
1.27% 
1.54% 
10.80% 
8.61% 3.15% 
12.42% 
7.04% 5.84% 
PI
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Figure 6. Confirmation of apoptosis using the DNA fragmentation assay. Cells were both 
untreated and treated with ACA for 12 hrs and 24 hrs to observe its effects on DNA 
laddering (M: 100 bp DNA Size Marker). 
 
Various plants species have been utilized as medicines for thousands of years, and traditional 
medicine has been a fertile source of novel lead molecules for modern drug discovery. In this study, 
MTT and flow cytometric assays were conducted with four main objectives: firstly, to determine 
whether the cytotoxic activity of ACA, a natural compound isolated from the Malaysian ethno-
medicinal plant Alpinia conchigera Griff., was dose or time dependant; secondly, to investigate the 
cytotoxic effects of 1’-(S)-1’-acetoxychavicol acetate (ACA) on normal cells; thirdly, to find out 
whether cell death was induced through apoptosis, and fourthly, to determine the IC50 values of ACA 
in each cancer cell type, which is crucial in subsequent downstream assays.  
Cells undergoing apoptosis can be observed via multiple hallmarks such as the appearance of a sub-
diploid DNA peak during PI-based cell cycle analysis, the staining of exposed phosphatidylserine on 
the cell surface which is demonstrated during annexin V-FITC/PI dual staining flow cytometry, and 
the consistent laddering of genomic DNA [17-18]. The fact that ACA induced cytotoxicity in a dose 
and time dependant manner was both important and convenient, as this allowed the manipulation and 
use of lower drug dosages with longer exposure periods, which can result in fewer side effects on non-
cancerous tissue. On the contrary, higher drug dosages with shorter exposure periods would also be 
beneficial when performing downstream assays involving protein and gene expression, as these assays 
are necessary to investigate drug mechanisms, and are generally conducted shortly upon drug exposure 
to capture intracellular molecular changes and events. 
Despite the fact that most toxicants may initiate cell damage or cell death, the cellular proteins that 
are involved in control of cell cycle and apoptosis are the final arbiters of cell fate. This study also 
demonstrates the ability of ACA to induce cell line-based arresting variations in cell cycle distribution 
patterns following treatment. The effect of ACA in terms of cell cycle arrest in this study has also been 
consistent with past reports in myeloma cells, indicating cell cycle arresting effects at the G0/G1 phase 
[19]. The appearance of a sub-G1 apoptotic peak describes a systematic anti-proliferative effect 
brought upon by ACA, where various cell division activities governed by various CDKs and cyclin 
proteins are halted, followed by cellular breakdown through the expression of apoptotic effector 
proteins. Additionally, cell cycle arrest incidences also provide a clear indication that the p53 pathway 
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is somewhat involved, hence a probable target of ACA. This anti-proliferative modulation of ACA is 
desirable, and provides a more gradual killing of cancer cells in comparison to certain anti-cancer 
drugs such as cisplatin and gemcitaine-HCl, which in general, imposes a more aggressive effect 
through the direct interference of DNA replication as means of cellular termination. 
The outer membrane protrusion of phosphatidylserine, a common phosphoprotein which is typically 
inaccessible in viable cells, is detected by annexin V-FITC, and indicates the early stages of apoptosis. 
This hallmark is part of a sequence of events leading to the loss of membrane integrity, hence allowing 
fluorescence PI dyes to permeate into the cell to bind nuclei acid, marking the entry of late apoptosis 
and secondary necrosis [20]. The ability of ACA to induce apoptosis was then confirmed with the 
conventional DNA fragmentation assay. Unlike necrotic cells where DNA is randomly degraded by a 
range of nucleases, apoptotic cells go through a systematic breakdown of DNA by endonucleases at 
specific exposed points of the DNA that are not protected by histone protein complexes [21]. This 
study showed that DNA fragmentation of cancer cell lines following ACA treatment was consistent 
with both previous MTT and flow cytometry assays, where partial killing of cells were observed 
within 24 hrs of exposure. 
3. Experimental  
3.1. General 
All spectral data were obtained on the following instruments: IR on a Perkin Elmer RX1 FT-IR 
spectrometer, UV on a Shimadzu UV-160A UV-Visible Recording Spectrophotometer, NMR on a 
JEOL (Japan Electronic Optics Laboratory Co. Ltd., Tokyo, Japan) JNM-LA400 FT-NMR 
spectrometer system (400 MHz) and MS on a Shimadzu GC-MS spectrometer (HP 6890 Series Mass 
Selective Detector and HP 6890 Series GC System). 
3.2. Chemicals 
RPMI-1640, fetal bovine serum (FBS) and all antibiotics were purchased from Lonza Inc. (USA). 
MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) reagent, Annexin V-
FITC/PI apoptosis detection kit, propidium iodide (PI), RNase A and Suicide Track™ DNA Ladder 
Isolation Kit were purchased from EMD Chemicals Inc. (Calbiochem, San Diego, CA, USA).  
3.3. Plant Materials 
The rhizomes of wild Alpinia conchigera Griff were collected from Jeli, province of Kelantan, east-
coast of Peninsular Malaysia. The sample was identified by Halijah Ibrahim from the Institute of 
Biological Science, Faculty of Science, University of Malaya. A voucher specimen (KL5049) was 
deposited in the Herbarium of Chemistry Department, Faculty of Science, University of Malaya. 
3.4. Extraction and Isolation 
Air-dried and powdered rhizomes of Alpinia conchigera (2.1 kg) were extracted with 
dichloromethane (7.0 L) at room temperature (72 hrs). The solvent was evaporated in vacuo to give the 
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dichloromethane extract, which was subjected to column chromatography (CC) on silica gel (Merck 
Kiesegel 60) eluting with a stepwise gradient of hexane-ethyl acetate (100:0 → 50:50). The fractions 
were collected separately and concentrated in vacuo at 40 °C. The fractions with similar TLC profiles 
were pooled together to give six sub-fractions which were then subjected to further chromatographic 
analysis, which yielded 1’-(S)-1’-acetoxychavicol acetate as the major constituent. The structure of this 
compound was determined based on comparison of its spectral data with those reported in the 
literatures [22-26].  
3.5. 1’-(S)-1’-Acetoxychavicol Acetate:  
A yellowish oil, Calculated for C13H14O4, 234.2479; Found 234, 192, 150, 149, 132, 104, 77. IR 
(CCl4) υmax, cm-1: 1761, 1645, 1234. UV λmax, nm: 304.5. 1H-NMR (CDCl3), δ: 2.08 (3H, s), 2.27  
(3H, s), 5.22 (2H, dd, J = 10.0 Hz), 5.98 (1H, m), 6.23 (1H, d, J = 5.8 Hz), 7.03 (2H, d, J = 8.8 Hz), 
7.33 (2H, d, J = 8.8 Hz). 13C-NMR (CDCl3), δ: 21.2 (CH3), 21.3 (CH3), 75.6 (CH), 117.2 (CH2), 121.7 
(2CH), 128.5 (2CH), 136.1 (CH), 136.5 (C), 150.5 (C), 169.4 (C), 169.7 (C). 
3.6. LCMS Analysis 
The LCMS analysis was done using Shimadzu LCMS-IT-TOF instrument (Columbia, MD, USA) 
equipped with a binary pump, an automatic injector and a photodiode array detector (SPD-M20A). The 
separation was carried out on a Waters Xbridge C18 column (50 × 2.1 mm, 2.5 µm). A binary gradient 
solvent system of double-distilled water (eluent A)—acetonitrile (eluent B) was used as follows: 100% 
A and 0% B (0.0 min), 0% A and 100% B (6.0 min), 100% A and 0% B (8.5–10.0 min). A flow-rate of 
0.5 mL/min was used and absorbance was detected at 254 nm. The solution was filtered through 
Whatman 13 mm, 0.2 µm nylon membrane syringe filters before use.  
3.7. Cultivation of Cells 
A total of five tumour cell lines were used in this study. Human breast adenocarcinoma (MCF-7) 
and oral squamous carcinoma (HSC-2 and HSC-4) were obtained from the Cancer Research Initiative 
Foundation (CARIF, Malaysia), while human hepatocyte carcinoma (HepG2) and epidermoid cervical 
carcinoma (CaSki) cells were obtained from the University Malaya Medical Centre (UMMC, 
Malaysia). Human mammary epithelial cells (HMEC) (Lonza, USA) were used as normal cell 
controls. All cells were cultured in DMEM except MCF-7 cells which were cultured as monolayers in 
RPMI 1640, supplemented with 10.0% (v/v) FBS, 100.0 U/mL penicillin and 100.0 µg/mL 
streptomycin. Cultures were maintained in a humidified CO2 incubator at 37 °C in 5.0% CO2 and 
95.0% air.  
3.8. Cell Viability Assay 
Cell viability was determined using the MTT assay which measures mitochondrial activity in viable 
cells ACA was dissolved in DMSO to a final concentration of 10.0 mM. Briefly, 2.0 × 104 cells were 
treated in triplicates on 96-well plates in the presence or absence of ACA at final concentrations of 
10.0 µM to 80.0 µM up to 30 hrs. Final DMSO concentration in each experiment was maintained 
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below 0.05% (v/v) to prevent solvent induced cytotoxicty. 20.0 µl of MTT dye reagent (5.0 mg/ml) 
was added to each well and cells were incubated in the dark at 37 °C. After 2 hrs of incubation, the 
media containing excess dye was aspirated and 200.0 µL of DMSO was added to dissolve the purple 
formazan precipitates. A microtiter plate reader (Tecan Sunrise®, Switzerland) was used to detect 
absorbance at a test wavelength of 570 nm, with a reference wavelength of 650 nm.  
3.9. Cell Cycle Analysis 
Cell cycle analysis was performed using PI based staining methods. Briefly, ACA-treated and 
untreated cells were fixed in ice-cold 70.0% (v/v) ethanol and kept at –30 °C. Staining of nuclear DNA 
content was conducted by adding PI (50.0 µg/mL) and RNase A (10.0 mg/mL), followed by incubation 
at 37 °C for 30 mins in the dark. Fluorescence from a population of 1.0 × 104 cells was detected using 
the BD FACSCalibur™ flow cytometer at 488 nm and examined on the CellQuest Pro (IVD) software 
(Becton Dickenson, Mountain View, CA, USA). 
3.10. Annexin-V Apoptosis Assays 
Detection on the various stages of apoptosis was conducted using the Annexin V-FITC/PI apoptosis 
detection kit according to manufacturer’s protocol. Briefly, media binding reagent containing FITC-
conjugated annexin V anti-coagulant (200.0 µg/mg) was added to ACA treated and untreated cells, 
followed by 15 mins incubation at room temperature. All samples were centrifuged and re-suspended 
in 1X cold binding buffer and PI (30.0 µg/mL). Detection of signals from a 1.0 × 104 cell population 
was obtained using the BD FACSCalibur™ flow cytometer and examined on the CellQuest Pro  
IVD software.  
3.11. DNA Fragmentation Assays 
Total DNA was extracted from both untreated and treated cells using the Suicide Track™ DNA 
Ladder Isolation Kit according to the manufacturer’s protocol. Extracted DNA was analyzed on a  
1.0% (w/v) agarose gel electrophoresis and stained with ethidium bromide. Fragmentation of DNA was 
observed under UV illumination and visualized using a gel documentation system (Alpha Inotech, USA). 
3.12. Statistical Analysis 
Results were expressed as mean values with ± standard error of the mean (SEM). All data were 
performed in triplicates and analyzed using one-way ANOVA, where differences were considered 
significant at p ≤ 0.05. 
4. Conclusions 
This study describes the initial drug development process chain beginning from compound isolation 
to biological pre-screening assays, and finally to apoptotic assays, confirming the apoptotic inducing 
effects of ACA on various cancer cell lines, the identification of pathways and genes modulated are 
vital in the drug development process chain in order to fully understand its apoptotic-inducing 
machinery. The knowledge and understanding on how ACA potentiates apoptosis as shown in this 
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study is of great importance in further understanding the mechanisms underlying tumourigenesis. This 
knowledge will provide the basis for newly targeted therapies, hence giving cancer researchers a better 
insight for future chemotherapeutic approaches. 
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